Keysource Blog

Keysource completes Global Data Centre Review for Pharmaceutical Giant

Jul 26, 2018 10:47:48 AM

Critical environment specialist Keysource has completed a global strategic data centre review for an international pharmaceuticals firm.

The project saw the business undertake a three-month assessment of 11 data centres in America, Hong Kong, Canada, China, Australia and in Britain to audit the pharma giant’s IT infrastructure.

Keysource’s review included an assessment of the data centre estate against a number industry standards. This also saw the team develop a road map for investing in the on-premise facilities that detailed where capex would be best directed to support the clients’ wider IT transformation strategy.

The critical environment specialist is now providing continued ongoing support following the recommendation advising on actions from the audit and service continuity.

Richard Clifford, data centre consultant and head of innovation at Keysource, said:

“We are finding that a lot of the global consultancy we are currently called on to provide relates to large, distributed IT estates, which present significant operational challenges."

“At Keysource we aim to gain a detailed understanding of our customers IT services and business objectives. This includes looking at the potential risks, the likely costs of maintenance and repairs, as well as any inefficiencies in the existing assets and allows us to these then shape recommendations for short or long-term strategies."

“Undertaking a global audit of data centres and server rooms in a consistent way can be quite an undertaking. Our expertise in both the design and operation of critical data centre environments puts Keysource in a unique position to help global businesses ensure they develop an informed IT delivery model to meet the demands of the future.”

Topics: News, Data Centre, Industry, pharmaceuticals


Written by Keysource